Abstract Purpose: To prepare and evaluate some 2-piperidinomethylamino-4-(7-H/substitutedcoumarin-3-yl)-6-chlorosubstitutedphenyl pyrimidines as antimicrobial agents.
INTRODUCTION
Microbial infections have been creating problems for mankind since centuries and scientists have also developed a large number of antimicrobial agents for the treatment of these infections. According to one new report, about 40 new microbial diseases have been identified since 1970s and more than 2 million Americans are suffering from antibiotic resistance, of which about 23000 die each year [1] . Because of the development of antibiotic resistance and emergence of new microbial diseases, there is a need to develop new antimicrobial agents for the treatment of microbial infections.
Pyrimidine derivatives have an important place in medicinal chemistry as these are associated with a broad range of biological activities [2] [3] [4] [5] [6] [7] including antimicrobial activity [8] [9] [10] [11] [12] [13] . The clinical importance of pyrimidine nucleus is also evident by the marketing of clinically used pyrimidine derivatives as well as fused pyrimidine derivatives; for example, as antineoplastic agent (tegafur), as vasodilator (dipyridamole), as expectorant (tasuldine) and as antibacterial agent (trimethoprim, piromidic acid, tetroxoprim, metioprim), as antifungal agent (flucytosine), and as antiviral agent (broxuridine, idoxuridine) [14] . Recently, the significance and biological importance of pyrimidine derivatives including their clinical applications in the microbial world has been reviewed [15] . The antimicrobial activity of pyrimidine derivatives against broad range of microbes makes it an important skeleton in medicinal chemistry and drug development against microbes. The piperidine nucleus is also an important moiety in medicinal chemistry research [16] . A number of piperidine ring containing chemical compounds have also been reported as antimicrobial agents [17] [18] [19] [20] .
Encouraged by these observations and also in continuation of our search for potent antimicrobial agents [21, 22] including antimicrobial agents having coumarin moiety [23] [24] [25] , we decided to prepare some 2-piperidinomethylamino-4-(7-H/substitutedcoumarin-3-yl)-6-chlorosubstitutedphenyl pyrimidines, herein after the title compounds (1a-18a), as antimicrobial agents.
EXPERIMENTAL General
Melting points were measured in open capillary tubes and are uncorrected. IR (KBr) spectra were recorded on a Nicolet, 5PC FT-IR spectrometer (Browser Morner, USA) and 1H-NMR/13C-NMR spectra on a Bruker DRX-300 FT NMR (Bruker, Germany) spectrophotometer using TMS as internal reference (chemical shift in δ ppm). Mass spectra were recorded on a Jeol-JMS-D-300 mass spectrometer (70 eV) (Jeol, Japan). Satisfactory analysis for C, H, and N was obtained for the compounds within ± 0.4 % of the theoretical values. Purity of the compounds was checked on silica gel G plates using iodine vapours as visualizing agent. Rf value of the compounds was determined by using a mixture of benzene and acetone (9:1). All reagents used in the present work were of analytical grade. The synthetic pathway for the preparation of the title compounds (1a-18a) is provided in Fig. 1 . The 2-amino-4-(7-H/substitutedcoumarin-3-yl)-6-(chlorosubstitutedphenyl) pyrimidines (1-18) prepared according to our previous report [23] were reacted with piperidine and formaldehyde in absolute ethanol to provide the title compounds (1a-18a).
General method for the synthesis (1a-18a)
A mixture of 2-amino-4-(7-H/substitutedcoumarin-3-yl)-6-chlorosubstituted phenyl pyrimidines (0.01 mole), piperidine (0.01 mole) and formaldehyde (0.015 moles) was refluxed in absolute ethanol for 8 to 12 h. The reaction mixture was reduced to half of its volume and poured on crushed ice. The solid separated was filtered, washed with water repeatedly, dried and recrystallized from ethanol.
Evaluation of antimicrobial activity
The title compounds (1a-18a) were tested for their in vitro antimicrobial activity by serial plate dilution method [26, 27] 
Statistical analysis
All antimicrobial activity data are presented as mean ± standard error of the mean (SEM, n = 6). The data were analyzed by one-way analysis of variance (ANOVA) with Dunnett's multiple comparison test with respect to control and standard groups using GraphPad Prism version 5.00 for Windows (GraphPad Software, San Diego California USA). The results were considered significantly different at p < 0.05.
RESULTS
The title compounds (1a-18a) were successfully prepared according to the method outlined in N-CH 2 -N chlorocoumarin-3-yl)-6-(3,5-dichlorophenyl )-4-(7-bromocoumarin-3-yl)-6-(3,4-dichlorophenyl 
2-(Piperidinomethylamino)-4-(7-bromocoumarin-3-yl)-6-(2,5-dichlorophenyl) pyrimidine (14a)
Yield
2-(Piperidinomethylamino)-4-(7-

2-(Piperidinomethylamino)-4-(7-bromocoumarin-3-yl)-6-(3,5-dichlorophenyl) pyrimidine (16a)
2-(Piperidinomethylamino)-4-(7-chlorocoumarin-3-yl)-6-(3,4-dichlorophenyl) pyrimidine (17a)
2-(Piperidinomethylamino
Antimicrobial activity
The antimicrobial activity data of the title compounds (1a-18a) at different concentrations against Gram positive bacteria, Gram negative bacteria and fungi is provided in Table 1, Table 2  and Table 3 , respectively. The zone of inhibition produced by the MIC of the standard drugs, ofloxacin and ketoconazole, has been considered as 100 % for comparing the antibacterial activity and antifungal activity data of the title compounds (1a-18a), respectively.
The antibacterial activity of ofloxacin against Gram positive bacteria revealed that it has a MIC value of 25 μg/mL against S. aureus, E. faecalis and S. epidermidis; and it has a MIC value of 12.5 μg/mL against B. subtilis and B. cereus. The antibacterial activity of the title compounds (1a-18a) with respect to ofloxacin revealed that the compound 6a (MIC = 50 μg/mL; p < 0. Compounds 2a (MIC = 25 μg/mL; p < 0.05), and 15a (MIC = 25 μg/mL; p < 0.0001) produced better antifungal activity against A. flavus than standard drug ketoconazole. Compounds 3a (MIC = 25 μg/mL; p < 0.0001), 11a (MIC = 25 μg/mL; p < 0.0001), 14a (MIC = 25 μg/mL; p < 0.0001), and 16a (MIC = 25 μg/mL; p < 0.0001) displayed better antifungal activity against M. purpureous than standard drug ketoconazole. Compounds 7a (MIC = 25 μg/mL; p < 0.0001), 9a (MIC = 25 μg/mL; p < 0.0001), 10a (MIC = 25 μg/mL; p < 0.0001), 11a (MIC = 25 μg/mL; p < 0.001), 14a (MIC = 25 μg/mL; p < 0.0001), 15a (MIC = 25 μg/mL; p < 0.05), and 18a (MIC = 25 μg/mL; p < 0.0001) also showed better antifungal activity against P. citrinum than standard drug ketoconazole. Other compounds did not produce noticeable antifungal activity even at higher concentrations with respect to standard drug ketoconazole.
DISCUSSION
A total of eighteen new compounds (1a-18a) were successfully synthesized, and their structures were confirmed on the basis of their IR, It is evident from the antimicrobial activity data mentioned in Table 1, Table 2 , and Table 3 that the title compounds are better antifungal agents than antibacterial agents. These results also support our earlier hypothesis [25] that the replacement of the morpholine moiety by its bioisosteres like piperidine moiety in these type of compounds may produce promising antifungal compounds. It is also evident from the antimicrobial activity data that these piperidine ring containing derivative are more potent antimicrobial agents than the reported morpholine ring containing derivatives [25] or the free amino group containing similar compounds [24] . It is also believed that the synthesized compounds might be inhibiting the growth of all tested microorganism by same mechanism as earlier reported pyrimidine moiety containing drugs [15] .
The structure activity relationship study of the title compounds (1a-18a) revealed that replacement of the morpholine ring [25] by the piperidine ring increases the overall antimicrobial activity of these type of compounds, predominantly the antifungal activity. The bromo group at 7-postion of the coumarin moiety along with the 4-chlorophenyl group at position-6 of the pyrimidine ring provides the most promising antimicrobial agent (6a) that is effective against Gram positive, Gram negative and fungi. The replacement of the 7-bromo group with the 7-chloro group, and presence of an additional chloro group at 4-cholorophenyl ring present at postion-6 of pyrimidine ring provides compound (17a) having promising antifungal activity. This structure activity relationship also suggests that the free amino group of the reported compounds [24] may further be exploited for the identification of more potent and safe antimicrobial agents.
CONCLUSION
It is evident from the antimicrobial activity data of the title compounds (1a-18a) that the compounds 6a and 17a are the promising antimicrobial agents of this series of compounds. However, these compounds produced promising effect at higher concentration, and therefore, are still considered to be less potent than standard drugs, ofloxacin and ketoconazole. There is a possibility that the replacement of the piperidine moiety by other similar type of chemical moieties, for example, pyrrolidine moiety may produce promising potent antimicrobial agents that are effective against Gram positive bacteria, Gram negative bacteria and fungi. Accordingly, this study may be extended to acquire more information about the structure activity relationships of this series of compounds.
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